Results 31 to 40 of about 2,912 (144)
Magnetic resonance findings of the corpus callosum in canine and feline lysosomal storage diseases.
Several reports have described magnetic resonance (MR) findings in canine and feline lysosomal storage diseases such as gangliosidoses and neuronal ceroid lipofuscinosis.
Daisuke Hasegawa +7 more
doaj +1 more source
The juvenile gangliosidoses: A timeline of clinical change
Background: The gangliosidoses are rare inherited diseases that result in pathologic accumulation of gangliosides in the central nervous system and other tissues, leading to severe and progressive neurological impairment and early death in the childhood ...
Kelly E. King +3 more
doaj +1 more source
Peripherally accessible biomarkers are urgently required to provide a prognosis for children with pre‐symptomatic Sanfilippo syndrome, enabling early trial/treatment access and optimal outcomes. Furthermore, clinical trials require biomarkers to better stratify patients into treatment groups and measure neurocognitive outcomes.
Leanne K. Winner +3 more
wiley +1 more source
Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses [PDF]
Mice containing a disruption of the Hexb gene have provided a useful model system for the study of the human lysosomal storage disorder known as Sandhoff disease (SD). Hexb(-/-) mice rapidly develop a progressive neurologic disease of ganglioside GM2 and GA2 storage.
Akira, Yamaguchi +5 more
openaire +2 more sources
Sandhoff disease, one of the GM2 gangliosidoses, is a lysosomal storage disorder characterized by the absence of β-hexosaminidase A and B activity and the concomitant lysosomal accumulation of its substrate, GM2 ganglioside.
Maria L. Allende +8 more
doaj +1 more source
Supplementary information for the manuscript "CRISPR/nCas9-based genome editing on GM2 gangliosidoses fibroblasts via non-viral vectors" submitted to the International Journal of Molecular Sciences.
Leal, Andrés +7 more
core +1 more source
Efficacy of a Bicistronic Vector for Correction of Sandhoff Disease in a Mouse Model
GM2 gangliosidoses are a family of severe neurodegenerative disorders resulting from a deficiency in the β-hexosaminidase A enzyme. These disorders include Tay-Sachs disease and Sandhoff disease, caused by mutations in the HEXA gene and HEXB gene ...
Evan Woodley +6 more
doaj +1 more source
Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses
Bis(monoacylglycero)phosphate (BMP) is a negatively charged glycerophospholipid with an unusual sn-1;sn-1′ structural configuration. BMP is primarily enriched in endosomal/lysosomal membranes.
Zeynep Akgoc +5 more
doaj +1 more source
Natural history study of glycan accumulation in large animal models of GM2 gangliosidoses [PDF]
beta-hexosaminidase is an enzyme responsible for the degradation of gangliosides, glycans, and other glycoconjugates containing beta-linked hexosamines that enter the lysosome.
Crawford, Brett E. +8 more
core +1 more source
(1) Lysosomal storage diseases are rare inherited disorders with no standardized or commercially available tests for biochemical diagnosis. We present factors influencing the quality of enzyme assays for metachromatic leukodystrophy (MLD) and ...
Sebastian Strobel +6 more
doaj +1 more source

